KRT17 and neoplasm: Overall, these lines of exploration may uncover how tumor cell-intrinsic immunomodulatory proteins, including K17, may shield PDAC from the development of effective immune responses and may highlight opportunities for further exploration to develop novel and more effective immunotherapeutic approaches for PDAC.